Alliance Memory COVID-19 Update: Operations Continue Without Disruption; Company Delivering SRAMs and DRAMs to Medical Customers With Normal Lead Times

KIRKLAND, Wash. — April 15, 2020 — Alliance Memory today announced that the company’s operations are continuing without disruption during the COVID-19 outbreak. For its customers in the medical market, Alliance Memory’s SRAM and DRAM products — key components in a wide range of medical equipment — are being delivered from stock or with normal lead times.

“The coronavirus pandemic is having no appreciable effect on our operations,” said David Bagby, president and CEO of Alliance Memory. “Continuation of our production is secured based on sufficient stock and deliveries, while our employees are either working from home or on-site in teams and shifts and following government guidelines by keeping the obligatory social distance and avoiding direct person-to-person contact. Our Taiwan office and test and assembly partners are operating normally, and customer consulting and support are also available. As a result, our medical ICs for critical medical equipment are being delivered as usual, allowing our customers to continue providing their life-sustaining solutions around the world.”

Alliance Memory supplies SRAMs and DRAMs to customers in all facets of the medical industry. Typical end products include ventilators; lasers; ultrasound, physiotherapy, cardiology, and radiology technologies; CPAP machines; molecular, in-vitro, and blood gas diagnostic testing equipment; X-ray systems; PEC/CT scanners; pulse oximetry and airway clearance devices; defibrillators; blood pressure monitors; incubators; and more.